Skip to main content

Proliferation in Pituitary Adenomas: Measurement by MAb KI 67

  • Conference paper
Processes of the Cranial Midline

Part of the book series: Acta Neurochirurgica Supplementum ((NEUROCHIRURGICA,volume 53))

Summary

The monoclonal antibody MAb KI 67 reacts with a nuclear antigen throughout the entire cell cycle and allows easy evaluation of proliferating tumour cells on routinely prepared smear and frozen sections. 120 pituitary adenomas were investigated by use of the monoclonal antibody KI 67 in a two-step avidin-biotin-peroxidase complex (ABC) technique. The KI 67 labelling index (LI) ranged in all adenomas from 0.2 to 4.6%. In 90 cases of transphenoidally operated adenomas the dura of the sella floor was investigated histologically. Adenomas with histologically proven dural infiltration showed a statistically significant higher KI 67 LI (p < 0.001) compared to non-invasive adenomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ciric I, Mikhael M, Stanford T, Lawson L (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long term follow up results. J Neurosurg 59: 395–402

    Article  PubMed  CAS  Google Scholar 

  2. Cooper EH, Frank GL, Wright DH (1966) Cell proliferation in Burkitt tumors. Europ J Cancer 2: 377–384

    Article  CAS  Google Scholar 

  3. Ebershold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV (1986) Long term results in transsphenoidal removal of non functioning pituitary adenomas. J Neurosurg 64: 713–719

    Article  Google Scholar 

  4. Fahlbusch R, Buchfelder M, Schreu K (1987) Short time preoperative treatment of macroprolactinomas by dopamine agonists. J Neurosurg 67: 807–815

    Article  PubMed  CAS  Google Scholar 

  5. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20

    Article  PubMed  CAS  Google Scholar 

  6. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody KI 67. J Immunol 113: 1710–1715

    Google Scholar 

  7. Goz B (1977) The effects of incorporation of 5 halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmakol Rev 29: 247–272

    Google Scholar 

  8. Gratzner HG (1982) Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474–475

    Article  PubMed  CAS  Google Scholar 

  9. Guesdon JL, Ternynck T, Avrameas S (1979) The use of avidinbiotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27: 1131–1139

    Article  PubMed  CAS  Google Scholar 

  10. Hardy J (1969) Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16: 185–217

    PubMed  CAS  Google Scholar 

  11. Hardy J (1983) Transsphenoidal microsurgery of prolactinomas: Report of 355 cases. In: Tolis G, Stefanis C, Mountokalakis T (eds) Prolactin and prolactinomas. Raven Press, New York, pp 431–440

    Google Scholar 

  12. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotropic adenomas of the human pituitary gland: A histopathologic immunocytologic and ultra-structural study. Am J Pathol 98: 617–638

    PubMed  CAS  Google Scholar 

  13. Horvath E, Kovacs K, Singer W, Ezrin C, Kerenyi A (1977) Acidophil stemcell adenoma of the human pituitary. Arch Pathol Lab Med 101: 594–599

    PubMed  CAS  Google Scholar 

  14. Hoshino T, Nagashima T, Murovic JA (1986) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxy- uridine labeling. J Neurosurg 64: 453–459

    Article  PubMed  CAS  Google Scholar 

  15. Hsu SM, Raine L, Fanger H (1981) Use of Avidine-Biotin- Peroxidase Complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577–580

    Article  PubMed  CAS  Google Scholar 

  16. Hubbard JL, Scheithauer BW, Abboud CHF, Laws ER (1967) Prolactin secreting adenomas: The preoperative response to bromocriptine treatment and surgical outcome. J Neurosurg 67: 816–821

    Google Scholar 

  17. Johnson HA, Haymaker WE, Rubini JR (1960) A radioauto- graphic study of a human brain and glioblastoma multiforme after in vivo uptake of tritiated thymidine. Cancer 13: 636–642

    Article  PubMed  CAS  Google Scholar 

  18. Knosp E, Krisch K, Schmidbauer M, Budka H (1988) Immunologischer Hormonnachweis bei Hypophysenadenomen: Korrelation von Serumhormonbefunden mit immunzyto- chemischem Hormonbefund am Tumorschnitt. Wien Klin Wochenschr 100: 322–325

    PubMed  CAS  Google Scholar 

  19. Knosp E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody KI 67. Neurosurg 25: 927–930

    Article  CAS  Google Scholar 

  20. Kovacs K (1984) Light and electron microscopic pathology of pituitary tumors: Immunohistochemistry. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 365–375

    Google Scholar 

  21. Landolt AM (1980) Biology of pituitary microadenomas. In: Faglia G, Giovanelli MA, Mac Leod RM (eds) Pituitary microadenomas. Academic Press, London, pp 107–122

    Google Scholar 

  22. Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67: 803–806

    Article  PubMed  CAS  Google Scholar 

  23. Landolt AM, Shibata T, Kleihues P, Tuncdogan E (1988) Growth of pituitary adenomas: Facts and speculations. Adv Biosciences 69: 53–62

    Google Scholar 

  24. Laws ER, Piepgras DG, Rendali RV (1979) Neurosurgical management of acromegaly: Results in 82 patients treated between 1972–1977. J Neurosurg 50: 454–461

    Article  PubMed  Google Scholar 

  25. Laws ER (1984) The Neurosurgical management of acromegaly. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 169–173

    Google Scholar 

  26. Martins AN, Hayes GJ, Kempe LG (1985) Invasive pituitary adenomas. J Neurosurg 22: 268–276

    Google Scholar 

  27. Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S-phase cells by a new in vitro BrdU labeling technique and of proliferating pool cells by monoclonal antibody KI 67. Acta Neuropathol (Beri) 77: 276–282

    Article  CAS  Google Scholar 

  28. Nagashima T, Murovic JA, Hoshino T, Wilson CB, Dearmond SJ (1986) The proliferative potential of human pituitary tumours in situ. J Neurosurg 64: 588–594

    Article  PubMed  CAS  Google Scholar 

  29. Nagashima T, Hoshino T, Cho KG, Senegor M, Waldman F, Nomura K (1988) Comparison of bromodesoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumours. J Neurosurg 68: 388–392

    Article  PubMed  CAS  Google Scholar 

  30. Naritoku WY, Taylor CR (1982) A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: An evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase. J Histochem Cytochem 30: 253–260

    Article  PubMed  CAS  Google Scholar 

  31. Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H (1988) Cell kinetic studies of human brain tumors by in vitro labeling using anti BrdU monoclonal antibody. J Neurosurg 69: 371–374

    Article  PubMed  CAS  Google Scholar 

  32. Ross DA, Wilson CB (1988) Results of transsphenoidal microsurgery for growth hormone secreting pituitary adenomas in a series of 214 patients. J Neurosurg 68: 854–867

    Article  PubMed  CAS  Google Scholar 

  33. Seager W (1977) Die Hypophysentumore: Zytologische und ultrastrukturelle Klassifikation, Pathogenese, endokrine Funktionen und Tierexperimente. Fischer G, Stuttgart New York, pp 39–42

    Google Scholar 

  34. Selman WR, Laws ER, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64: 402–408

    Article  PubMed  CAS  Google Scholar 

  35. Scheithauer BW, Kovacs KT, Laws ER, Randall RV (1986) Pathology in invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733–745

    Article  PubMed  CAS  Google Scholar 

  36. Tindall GT, Tindall SC (1984) Transsphenoidal surgery for acromegaly; Long term results in 50 patients. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 175–178

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag

About this paper

Cite this paper

Kitz, K., Knosp, E., Koos, W.T., Korn, A. (1991). Proliferation in Pituitary Adenomas: Measurement by MAb KI 67. In: Koos, W., Richling, B. (eds) Processes of the Cranial Midline. Acta Neurochirurgica Supplementum, vol 53. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9183-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9183-5_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-9185-9

  • Online ISBN: 978-3-7091-9183-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics